Path2Quit Tobacco Intervention For African Americans

March 27, 2019 updated by: Case Comprehensive Cancer Center

Development and Pilot Evaluation of the Path2Quit Tobacco Intervention Targeting African Americans

The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.

The study includes completing surveys and receiving text messages to help participants become tobacco free.

Study Overview

Detailed Description

OBJECTIVES Specific Aim 1: Translate a culturally specific video-based tobacco use intervention into a scalable mobile health (mhealth) format.

Specific Aim 2: Conduct a pilot study of the video-text intervention.

Study Design:

2-arm semi-pragmatic randomized design among current tobacco users

Cuyahoga Metropolitan Housing Authority residents will be randomly assigned to receive (1) the newly translated Path2Quit or (2) SmokeFreeText (NCI's publicly available, standard text messaging program) combined with brief behavioral counseling session plus 2 weeks of nicotine replacement therapy (NRT). Primary outcomes will include intervention evaluations (content and format), acceptability, coping strategies, engagement, and NRT adherence. Secondary variables will include 24-hour quit attempts and biochemically verified tobacco use abstinence at the 1-month follow-up. Exploratory mediational analyses will examine the roles of urban hassles, acculturation, neighborhood environment, ethnic discrimination, and psychological distress in intervention effects.

Study Type

Interventional

Enrollment (Actual)

119

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44106
        • Case Western Reserve University, Case Comprehensive Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Self-identify as African American
  • Either smoke at least 1 cigarettes/day or have a carbon monoxide (CO) reading of at least 4 ppm
  • Consistent with SmokefreeTXT, be willing to set a quit date within the next 14 days.
  • Recruited from Cleveland metropolitan housing authority or who report low income based on federal guidelines

Exclusion Criteria:

  • Does not meet all of the above inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Path2Quit
Culturally specific text message intervention
Path2Quit will deliver 20-60 second video clips by multimedia messaging service. The message library will include 75-170 messages. Written text messages will be limited to brief phrases to indicate the topic of the video. Messages will be pushed to participants in the morning, in the afternoon, and 2 hours before the reported usual bedtime. The cultural adaptations will be infused throughout the video segments. Topics include deep structure: race and smoking in general, African American smoking statistics; norms for smoking; concerns about nicotine replacement/medication; family/collectivism; unique stressors; racism/discrimination, depression; co-morbid addiction; neighborhood/environmental influences; menthol cigarettes; race-specific weight issues and concerns; and working as a community against the tobacco industry.
Active Comparator: SmokeFreeText
The National Cancer Institute's publicly available, standard text messaging program for tobacco cessation
SmokefreeTXT is a 6-8 week fully automated text-based cessation intervention. The program is free to U.S. subscribers who have a mobile phone, and is available on smokefree.gov or by texting "QUIT" to short code 47848. Participants are encouraged to set a quit date within the next 14 days, followed by count-down messages leading to the quit date. Starting on the quit date, participants receive 6 weeks of intervention text messages, and assessment questions (mood, cravings, smoking status). The message library contains 166 messages and 41 behavior change techniques,40 which are delivered at the greatest frequency during the first 2 weeks and taper over time. When in need of assistance, participants can text one of 3 keywords (MOOD, CRAVE, or SLIP) to receive a relevant message from the system. Participants can opt-out by texting STOP at any time. With informed consent, we will be able to access the SmokefreeTXT data for these participants.
Other Names:
  • SmokefreeTXT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of participants who abstain from smoking
Time Frame: At 1-month follow-up
Abstinence will be coded as a binary variable. Analysis will be conducted with an intent to treat approach
At 1-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of missed nicotine replacement therapy doses
Time Frame: Up to 1-month follow-up
Measure of NRT adherence. Number of missed doses will be recorded for each participant
Up to 1-month follow-up
24-Hour quit attempts
Time Frame: At 1-month follow-up
Number of times a participant quits smoking for at least 24 hours
At 1-month follow-up
Changes in carbon monoxide breath levels from baseline to followup
Time Frame: At 1-month follow-up
Breath carbon monoxide tests will biochemically confirm self-reported cessation
At 1-month follow-up
Changes in Contemplation ladder score
Time Frame: From baseline to up to 1-month follow-up
self-reported score 0-10 where a higher score indicates more readiness to quit
From baseline to up to 1-month follow-up
Average score of Intervention Evaluation (IRQ)
Time Frame: At 1-month follow-up
The IRQ is a 22 item scale scored 0-7 (total score 0-154) where higher scores indicate more satisfaction
At 1-month follow-up
Average score of smoking urges
Time Frame: Up to 1-month follow-up
This brief, 10 item scale is scores 1-7 (total score 10-70) with higher scores indicating greater agreement
Up to 1-month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average scores of Urban hassles
Time Frame: Changes from baseline to 1 month follow-up
This is a 63 item scale scored 0-5 (total score 0-315) where higher scores indicate more severe hassle
Changes from baseline to 1 month follow-up
Average Neighborhood Environment scale score
Time Frame: At Baseline
The neighborhood environment scale is an 18 item True or False scale
At Baseline
Average General Ethnic Discrimination Scale Score
Time Frame: At baseline
This is a measure of ethnic discrimination. These 16 items are scored 1-6 (total score 16-96) with higher scores indicating greater levels of ethnic discrimination
At baseline
Average psychological distress score using the the perceived stress scale
Time Frame: At baseline
A ten item scale with each item scored 0-4 (total score 0-40) where higher scores indicate more stress. Positive items are scored in reverse.
At baseline
Average depression score using Center for Epidemiological Studies Depression (CES-D) Scale
Time Frame: At baseline
A twenty item scale ranging from 0-60 with each item scored 0-3. Higher scores indicate more depression
At baseline
Average Beliefs and Attitudes Survey Score
Time Frame: At baseline
This is a 24 item scale (total range 24-168) with each item scored 1-7. Higher scores indicate greater levels of agreement
At baseline
Average Ethnic Identity Score
Time Frame: At baseline
This is based on the Multigroup Ethnic Identity Measure scale. These five items are scored 1-4 for a total score of 5-20. Higher scores indicate stronger ethnic identity
At baseline
Average Culturally Specific Interventions Expectancy Questionnaire
Time Frame: At baseline
The Culturally Specific Interventions Expectancy Questionnaire is a 2 item scale with each item ranging 1-5 (total score 2-10) where higher scores indicate greater agreement.
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Monica Webb Hooper, PhD, Case Comprehensive Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Actual)

August 20, 2018

Study Completion (Actual)

August 20, 2018

Study Registration Dates

First Submitted

April 30, 2018

First Submitted That Met QC Criteria

May 11, 2018

First Posted (Actual)

May 14, 2018

Study Record Updates

Last Update Posted (Actual)

March 28, 2019

Last Update Submitted That Met QC Criteria

March 27, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • CASE1Y18

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Path2Quit

3
Subscribe